Creatine: Difference between revisions
>LockPicker m Legal issues== -> ==Legal status |
>Mattyboi m Minor grammar error fix in "Toxicity and harm potential" |
||
Line 57: | Line 57: | ||
There are no clinically significant side-effects of creatine supplementation acutely. Numerous trials have been conducted in humans with varying dosages, and the side-effects have been limited to gastrointestinal distress (from too much creatine consumption at once) and cramping (from insufficient hydration). | There are no clinically significant side-effects of creatine supplementation acutely. Numerous trials have been conducted in humans with varying dosages, and the side-effects have been limited to gastrointestinal distress (from too much creatine consumption at once) and cramping (from insufficient hydration). | ||
Studies that use a dosage range typical of creatine supplementation (in the range of 5g a day following an acute loading period) note increases to total body water of 6.2% (3.74lbs) over nine weeks, 1.1kg over 42 days,<ref>Francaux, M., & Poortmans, J. R. (1999). Effects of training and creatine supplement on muscle strength and body mass. European Journal of Applied Physiology and Occupational Physiology, 80(2), 165–8. https://doi.org/10.1007/s004210050575</ref>. This effect may be responsible for creatine's capability to increase perceived body weight. | Studies that use a dosage range typical of creatine supplementation (in the range of 5g a day following an acute loading period) note increases to total body water of 6.2% (3.74lbs) over nine weeks, and 1.1kg (2.42 lbs) over 42 days,<ref>Francaux, M., & Poortmans, J. R. (1999). Effects of training and creatine supplement on muscle strength and body mass. European Journal of Applied Physiology and Occupational Physiology, 80(2), 165–8. https://doi.org/10.1007/s004210050575</ref>. This effect may be responsible for creatine's capability to increase perceived body weight. | ||
Regardless, it is strongly recommended that one is familiar with [[responsible drug use|harm reduction practices]] when using creatine. | Regardless, it is strongly recommended that one is familiar with [[responsible drug use|harm reduction practices]] when using creatine. | ||
Line 71: | Line 71: | ||
==Literature== | ==Literature== | ||
* M’Swiney, B. A. (1915). Creatine and creatinine. The Dublin Journal of Medical Science, 140(3), 175–191. https://doi.org/10.1007/BF02964439 | |||
* Francaux, M., & Poortmans, J. R. (1999). Effects of training and creatine supplement on muscle strength and body mass. European Journal of Applied Physiology and Occupational Physiology, 80(2), 165–168. https://doi.org/10.1007/s004210050575 | *M’Swiney, B. A. (1915). Creatine and creatinine. The Dublin Journal of Medical Science, 140(3), 175–191. https://doi.org/10.1007/BF02964439 | ||
* Persky, a M., & Brazeau, G. a. (2001). Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacological Reviews, 53(2), 161–176. https://doi.org/10.1124/pharmrev1 | *Francaux, M., & Poortmans, J. R. (1999). Effects of training and creatine supplement on muscle strength and body mass. European Journal of Applied Physiology and Occupational Physiology, 80(2), 165–168. https://doi.org/10.1007/s004210050575 | ||
* Metzl, J. D., Small, E., Levine, S. R., & Gershel, J. C. (2001). Creatine Use Among Young Athletes. PEDIATRICS, 108(2), 421–425. https://doi.org/10.1542/peds.108.2.421 | *Persky, a M., & Brazeau, G. a. (2001). Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacological Reviews, 53(2), 161–176. https://doi.org/10.1124/pharmrev1 | ||
* Brosnan, J. T., & Brosnan, M. E. (2007). Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annual Review of Nutrition, 27(December), 241–261. https://doi.org/10.1146/annurev.nutr.27.061406.093621 | *Metzl, J. D., Small, E., Levine, S. R., & Gershel, J. C. (2001). Creatine Use Among Young Athletes. PEDIATRICS, 108(2), 421–425. https://doi.org/10.1542/peds.108.2.421 | ||
* Hezave, A. Z., Aftab, S., & Esmaeilzadeh, F. (2010). Micronization of creatine monohydrate via Rapid Expansion of Supercritical Solution (RESS). Journal of Supercritical Fluids, 55(1), 316–324. https://doi.org/10.1016/j.supflu.2010.05.009 | *Brosnan, J. T., & Brosnan, M. E. (2007). Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annual Review of Nutrition, 27(December), 241–261. https://doi.org/10.1146/annurev.nutr.27.061406.093621 | ||
* Béard, E., & Braissant, O. (2010). Synthesis and transport of creatine in the CNS: Importance for cerebral functions. Journal of Neurochemistry, 115(2), 297–313. https://doi.org/10.1111/j.1471-4159.2010.06935.x | *Hezave, A. Z., Aftab, S., & Esmaeilzadeh, F. (2010). Micronization of creatine monohydrate via Rapid Expansion of Supercritical Solution (RESS). Journal of Supercritical Fluids, 55(1), 316–324. https://doi.org/10.1016/j.supflu.2010.05.009 | ||
* Nasrallah, F., Feki, M., & Kaabachi, N. (2010). Creatine and Creatine Deficiency Syndromes: Biochemical and Clinical Aspects. Pediatric Neurology, 42(3), 163–171. https://doi.org/10.1016/j.pediatrneurol.2009.07.015 | *Béard, E., & Braissant, O. (2010). Synthesis and transport of creatine in the CNS: Importance for cerebral functions. Journal of Neurochemistry, 115(2), 297–313. https://doi.org/10.1111/j.1471-4159.2010.06935.x | ||
* Tarnopolsky, M. A. (2010). Caffeine and Creatine Use in Sport. Annals of Nutrition and Metabolism, 57(s2), 1–8. https://doi.org/10.1159/000322696 | *Nasrallah, F., Feki, M., & Kaabachi, N. (2010). Creatine and Creatine Deficiency Syndromes: Biochemical and Clinical Aspects. Pediatric Neurology, 42(3), 163–171. https://doi.org/10.1016/j.pediatrneurol.2009.07.015 | ||
* Sahlin, K., & Harris, R. C. (2011). The creatine kinase reaction: a simple reaction with functional complexity. Amino Acids, 40(5), 1363–1367. https://doi.org/10.1007/s00726-011-0856-8 | *Tarnopolsky, M. A. (2010). Caffeine and Creatine Use in Sport. Annals of Nutrition and Metabolism, 57(s2), 1–8. https://doi.org/10.1159/000322696 | ||
* Beal, M. F. (2011). Neuroprotective effects of creatine. Amino Acids, 40(5), 1305–1313. https://doi.org/10.1007/s00726-011-0851-0 | *Sahlin, K., & Harris, R. C. (2011). The creatine kinase reaction: a simple reaction with functional complexity. Amino Acids, 40(5), 1363–1367. https://doi.org/10.1007/s00726-011-0856-8 | ||
* Turner, C. E., & Gant, N. (2014). The Biochemistry of Creatine. In Magnetic Resonance Spectroscopy (pp. 91–103). Elsevier. https://doi.org/10.1016/B978-0-12-401688-0.00007-0 | *Beal, M. F. (2011). Neuroprotective effects of creatine. Amino Acids, 40(5), 1305–1313. https://doi.org/10.1007/s00726-011-0851-0 | ||
*Turner, C. E., & Gant, N. (2014). The Biochemistry of Creatine. In Magnetic Resonance Spectroscopy (pp. 91–103). Elsevier. https://doi.org/10.1016/B978-0-12-401688-0.00007-0 | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Noopept]] | *[[Noopept]] | ||
Line 91: | Line 93: | ||
*[[Modafinil]] | *[[Modafinil]] | ||
*[[Pramiracetam]] | *[[Pramiracetam]] | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Creatine Creatine (Wikipedia)] | *[https://en.wikipedia.org/wiki/Creatine Creatine (Wikipedia)] | ||
*[https://examine.com/supplements/creatine/ Creatine (Examine)] | *[https://examine.com/supplements/creatine/ Creatine (Examine)] |